Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eyepoint Pharmaceuticals Inc (EYPT)

Eyepoint Pharmaceuticals Inc (EYPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 280,799
  • Shares Outstanding, K 28,741
  • Annual Sales, $ 34,440 K
  • Annual Income, $ -45,390 K
  • 60-Month Beta 1.34
  • Price/Sales 8.14
  • Price/Cash Flow N/A
  • Price/Book 8.95
Trade EYPT with:

Options Overview

Details
  • Implied Volatility 129.08%
  • Historical Volatility 75.33%
  • IV Percentile 9%
  • IV Rank 3.42%
  • IV High 1,133.87% on 08/19/20
  • IV Low 93.49% on 12/10/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 81
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 5,959
  • Open Int (30-Day) 1,606

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.52
  • Number of Estimates 2
  • High Estimate -0.47
  • Low Estimate -0.58
  • Prior Year -1.10
  • Growth Rate Est. (year over year) +52.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.78 +11.10%
on 04/12/21
12.11 -19.41%
on 03/16/21
-1.91 (-16.37%)
since 03/15/21
3-Month
8.78 +11.16%
on 03/05/21
15.06 -35.19%
on 02/18/21
-1.16 (-10.62%)
since 01/15/21
52-Week
3.51 +177.98%
on 10/28/20
15.06 -35.19%
on 02/18/21
+0.76 (+8.43%)
since 04/15/20

Most Recent Stories

More News
EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates

EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -324.44% and -70.39%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the...

EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 4, 2021 / EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 4, 2021...

EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today...

EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today...

EYPT : 9.70 (-0.72%)
Zacks.com featured highlights include: Stamps.com, Ribbon Communications, American Software and EyePoint Pharmaceuticals

Zacks.com featured highlights include: Stamps.com, Ribbon Communications, American Software and EyePoint Pharmaceuticals

AMSWA : 20.39 (-0.05%)
STMP : 212.50 (-0.12%)
RBBN : 8.45 (-0.12%)
EYPT : 9.70 (-0.72%)
4 Stocks in the Limelight on New Analyst Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Stamps.com Inc. (STMP), Ribbon Communications Inc. (RBBN), American Software, Inc. (AMSWA) and...

AMSWA : 20.39 (-0.05%)
STMP : 212.50 (-0.12%)
RBBN : 8.45 (-0.12%)
EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals Announces Closing of $115 Million Public Offering of Common Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today...

EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today...

EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today...

EYPT : 9.70 (-0.72%)
EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today...

EYPT : 9.70 (-0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 10.86
2nd Resistance Point 10.48
1st Resistance Point 10.13
Last Price 9.70
1st Support Level 9.40
2nd Support Level 9.02
3rd Support Level 8.67

See More

52-Week High 15.06
Fibonacci 61.8% 10.65
Last Price 9.70
Fibonacci 50% 9.29
Fibonacci 38.2% 7.92
52-Week Low 3.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar